Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia)

T. N. Komarov; N. S. Bagaeva; K. K. Karnakova; I. E. Shohin; K. Ya. Zaslavskaya; P. A. Bely

For citations:

Komarov T.N., Bagaeva N.S., Karnakova K.K., Shohin I.E., Zaslavskaya K.Ya., Bely P.A. Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia). Drug development & registration. 2023;12(2):146-153. (In Russ.) https://doi.org/10.33380/2305-2066-2023-12-2-146-153

Views PDF (Rus): 555

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Drug development & registration

For citations:

Cookies policy